Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Carsten P. Hansen"'
Autor:
Sidsel C. Lindgaard, Zsófia Sztupinszki, Emil Maag, Carsten P. Hansen, Inna M. Chen, Astrid Z. Johansen, Jane P. Hasselby, Stig E. Bojesen, Dorte Nielsen, Julia S. Johansen
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 3972-3986 (2023)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer death. Less than 20% of patients are diagnosed with resectable disease. Identifying truly resectable disease is challenging because 20%–40% of the pat
Externí odkaz:
https://doaj.org/article/fb52e57547d541348b9adfb96269d526
Autor:
Neel I. Nissen, Astrid Z. Johansen, Inna M. Chen, Christina Jensen, Emilie A. Madsen, Carsten P. Hansen, Jeppe Thorlacius-Ussing, Morten Karsdal, Julia S. Johansen, Hadi M. H. Diab, Lars N. Jørgensen, Nicholas Willumsen
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a pronounced fibrotic tumor microenvironment, which impairs treatment response. Type I and V collagens are responsible for the densely packed fibrils in the tumor fibrosis envi
Externí odkaz:
https://doaj.org/article/8f4be5d66b1d42658607a755ed58cc35
Autor:
Troels D. Christensen, Emil Maag, Ole Larsen, Claus L. Feltoft, Kaspar René Nielsen, Lars Henrik Jensen, Bonna Leerhøy, Carsten P. Hansen, Inna M. Chen, Dorte L. Nielsen, Julia S. Johansen
Publikováno v:
JHEP Reports, Vol 5, Iss 3, Pp 100648- (2023)
Background & Aims: Biliary tract cancer (BTC) is associated with a dismal prognosis, partly because it is typically diagnosed late, highlighting the need for diagnostic biomarkers. The purpose of this project was to identify and validate multiprotein
Externí odkaz:
https://doaj.org/article/51bf95d915174913b37fd8a23ae83013
Autor:
Emilie A. Madsen, Jeppe Thorlacius-Ussing, Neel I. Nissen, Christina Jensen, Inna M. Chen, Julia S. Johansen, Hadi M. H. Diab, Lars N. Jørgensen, Carsten P. Hansen, Morten A. Karsdal, Nicholas Willumsen
Publikováno v:
Cells, Vol 11, Iss 23, p 3763 (2022)
Circulating fragments of type III collagen, measured by PRO-C3, has shown promising results as a tumor fibrosis biomarker. However, the fibrotic tumor microenvironment consists of many other collagens with diverse functions and unexplored biomarker p
Externí odkaz:
https://doaj.org/article/46a77022ccbd47e297ef2d33349a1417
Autor:
Rasmus S. Pedersen, Neel I. Nissen, Christina Jensen, Jeppe Thorlacius-Ussing, Tina Manon-Jensen, Majken L. Olesen, Lasse L. Langholm, Hadi M. H. Diab, Lars N. Jorgensen, Carsten P. Hansen, Inna M. Chen, Julia S. Johansen, Morten A. Karsdal, Nicholas Willumsen
Publikováno v:
Biomolecules, Vol 12, Iss 9, p 1315 (2022)
Pancreatic ductal adenocarcinoma (PDAC) is a hard-to-treat cancer due to the collagen-rich (fibrotic) and immune-suppressed microenvironment. A major driver of this phenomenon is transforming growth factor beta (TGF-β). TGF-β is produced in an inac
Externí odkaz:
https://doaj.org/article/090d7e20b41848078ab5b37623004dd1
Autor:
Ingrid H. Olsen, Jens B. Sørensen, Birgitte Federspiel, Andreas Kjaer, Carsten P. Hansen, Ulrich Knigge, Seppo W. Langer
Publikováno v:
The Scientific World Journal, Vol 2012 (2012)
Background. Knowledge of the clinical efficacy in recurrent neuroendocrine carcinomas is sparse. Treatment with temozolomide alone or in combination with capecitabine and bevacizumab has recently shown promising results. Patients and Methods. Analysi
Externí odkaz:
https://doaj.org/article/813cffaf14b2462099cd81b897c97ecf
Autor:
Carsten Palnæs Hansen, Jan Henrik Storkholm, Martin Hylleholt Sillesen, Paul Suno Krohn, Stefan Kobbelgaard Burgdorf, Jens Georg Hillingsø
Publikováno v:
BMC Surgery, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background During the COVID pandemic there has been limited access to elective surgery including oncologic surgery in several countries world-wide. The aim of this study was to investigate if there was any lockdown effect on pancreatic surge
Externí odkaz:
https://doaj.org/article/283b715e75d24f5fa8767b0d2453dd96
Autor:
Susann Theile, Julia Sidenius Johansen, Dorte Lisbet Nielsen, Benny Vittrup Jensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Sverrir Vídalín Eiríksson, Inna Markovna Chen
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 509 (2022)
The antitumor activity of chitooligosaccharides has been suggested. This phase 2 trial evaluated the efficacy and safety of T-ChOS™, in addition to adjuvant chemotherapy, in patients after resection of pancreatic ductal adenocarcinoma (PDAC). In th
Externí odkaz:
https://doaj.org/article/5a0346c68163424ea72e48cb40bd3697
Autor:
Anna Bryan Stensbøl, Jesper Krogh, Pernille Holmager, Marianne Klose, Peter Oturai, Andreas Kjaer, Carsten Palnæs Hansen, Birgitte Federspiel, Seppo W. Langer, Ulrich Knigge, Mikkel Andreassen
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2030 (2021)
Background: The incidence of small intestinal (SI) and pancreatic neuroendocrine tumors (siNETs and pNETs) seems to have increased. The increased frequency of incidental findings might be a possible explanation. The study aimed to examine (1) changes
Externí odkaz:
https://doaj.org/article/7d8e6c2923734c5088515b0cfd7b050e
Autor:
Benjamin E. Stubbe, Poul H. Madsen, Anders C. Larsen, Henrik B. Krarup, Inge S. Pedersen, Carsten P. Hansen, Julia S. Johansen, Stine D. Henriksen, Ole Thorlacius-Ussing
Publikováno v:
Stubbe, B 2023, ' Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma ', Pancreatology . https://doi.org/10.1016/j.pan.2023.05.003
Stubbe, B, Madsen, P H, Larsen, A C, Krarup, H B, Pedersen, I S, Johansen, J S, Henriksen, S D & Thorlacius-Ussing, O 2023, ' Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma ', Pancreatology . https://doi.org/10.1016/j.pan.2023.05.003
Stubbe, B, Madsen, P H, Larsen, A C, Krarup, H B, Pedersen, I S, Johansen, J S, Henriksen, S D & Thorlacius-Ussing, O 2023, ' Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma ', Pancreatology . https://doi.org/10.1016/j.pan.2023.05.003
BackgroundPancreatic ductal adenocarcinoma remains one of the major causes of cancer-related mortality globally. Unfortunately, current prognostic biomarkers are limited, and no predictive biomarkers exist. This study examined promoter hypermethylati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de3cee6e3a023423872c6cc41de9e45c
https://vbn.aau.dk/da/publications/a5db5b62-6897-44f8-b46c-67413b030d2c
https://vbn.aau.dk/da/publications/a5db5b62-6897-44f8-b46c-67413b030d2c
